NCT04165837 - Safety, Tolerability, and Pharmacokinetics of Oral FB-101 in Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 14, 2019

Primary Completion Date

November 12, 2021

Study Completion Date

July 14, 2022

Conditions

Parkinson's Disease

Interventions

DRUG

FB-101

Part A - Single Ascending Dose study Part B - Multiple Ascending Dose study

DRUG

Placebo

Part A - Single Ascending Dose matching placebo study Part B - Multiple Ascending Dose matching placebo study

Trial Locations (1)

PAREXEL, Baltimore